-
Hanmi Pharmaceutical Signs Global Licensing Agreement with Gilead Sciences and Health Hope Pharma for Encequidar
29 Sep 2025 16:36 GMT
… groundbreaking global licensing agreement with Gilead Sciences, Inc., and Health Hope Pharma … ’s oral formulation applications.”
Hanmi CEO Jae-Hyun Park highlighted the …
-
Gilead Sciences, Inc. (GILD) Expands U.S. Manufacturing Capacity With $32B Investment Through 2030
21 Sep 2025 15:30 GMT
… to Buy Now. Gilead Sciences, Inc. is one of them. Gilead Sciences, Inc. (NASDAQ … biologics through AI integration. Under CEO Daniel O’Day, the company … Investment Through 2030 Beyond infrastructure, Gilead Sciences, Inc. (NASDAQ:GILD) is expanding …
-
SLB, Apple, Nvidia, Merck, Gilead Sciences: What Sparked Heavy After-Hours Trading In These 5 Stocks?
11 Sep 2025 06:55 GMT
… volume was at ‘normal’ levels.
Gilead Sciences, Inc. (GILD)
After-hours move … | source: StocktwitsRetail sentiment toward the Gilead Sciences stock remained ‘neutral’ (47… Next Week? What Goldman Sachs CEO David Solomon Predicts For September …
-
Gilead Sciences Commits to Veeva Vault CRM
10 Sep 2025 23:23 GMT
Gilead Sciences has committed to Veeva Vault … Anna Åsberg, global CIO at Gilead Sciences. “We share a deep commitment … , inflammation, and oncology,” said Veeva CEO Peter Gassner. “We are honored …
-
Gilead Sciences invests $32 billion to build pharmaceutical manufacturing facility in California
10 Sep 2025 16:38 GMT
Gilead Sciences has announced plans to build … quote, Toshiaki Tokunaga, President & CEO of Hitachi, said, “The United … recent quote, Daniel O’Day, CEO, Gilead Sciences, said that the five-story …
-
Gilead Sciences Breaks Ground on New Biomanufacturing Hub
05 Sep 2025 16:20 GMT
Gilead Sciences broke ground on its new … Daniel O’Day, chairman and CEO.
“This new facility is part …
-
Gilead Sciences advances HIV prevention with new US partnership
05 Sep 2025 11:04 GMT
Gilead Sciences has announced a collaboration with … lenacapavir for preventing HIV infection.
Gilead Sciences CEO and chairman Daniel O’Day …
-
Gilead Sciences Gains In Vivo Cell Therapy Capability With $350M Interius Bio Acquisition
22 Aug 2025 01:29 GMT
Gilead Sciences broke into the field of … is reshaping pharma, Reverba Global CEO Cheryl Lubbert explained in an …
-
Galapagos to Wind Down Cell Therapy Business After Search for a Buyer Comes Up Empty
22 Oct 2025 01:16 GMT
… that legacy Galapagos had with Gilead Sciences. Gilead retains an equity stake … moves by AstraZeneca, AbbVie, and Gilead Sciences. Each of those deals brings … the retiring Paul Stoffels as CEO.
Galapagos said the full wind …
-
Factory fallout: Manufacturing plant closures and layoffs from Dow, Gilead Sciences, Whitford, and more
11 Aug 2025 14:05 GMT
… quote, Jim Fitterling, Chair and CEO of Dow, said, “Our industry … more
According to WHYY News, Gilead Sciences has shut down the Tmunity …
About
© 1995-2025